BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37436606)

  • 21. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
    Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T
    Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and Validation of a Laboratory Risk Score (LabScore) to Predict Outcomes after Resection for Intrahepatic Cholangiocarcinoma.
    Tsilimigras DI; Mehta R; Aldrighetti L; Poultsides GA; Maithel SK; Martel G; Shen F; Koerkamp BG; Endo I; Pawlik TM;
    J Am Coll Surg; 2020 Apr; 230(4):381-391.e2. PubMed ID: 32014569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
    de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
    Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel online prognostic tool to predict long-term survival after liver resection for intrahepatic cholangiocarcinoma: The "metro-ticket" paradigm.
    Sahara K; Tsilimigras DI; Mehta R; Bagante F; Guglielmi A; Aldrighetti L; Alexandrescu S; Marques HP; Shen F; Koerkamp BG; Endo I; Pawlik TM
    J Surg Oncol; 2019 Aug; 120(2):223-230. PubMed ID: 31004365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is Radiotherapy Warranted Following Intrahepatic Cholangiocarcinoma Resection? The Impact of Surgical Margins and Lymph Node Status on Survival.
    Hammad AY; Berger NG; Eastwood D; Tsai S; Turaga KK; Christian KK; Johnston FM; Pawlik TM; Gamblin TC
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):912-920. PubMed ID: 27654107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of resection margin length after surgical resection for intrahepatic cholangiocarcinoma.
    Zhu H; Wang L; Wang M; He X; Xu W; Zhu W; Zhao Y; Wang L
    Am J Surg; 2021 Aug; 222(2):383-389. PubMed ID: 33388133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of body mass index on tumor recurrence among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma- a multi-institutional international analysis.
    Merath K; Mehta R; Hyer JM; Bagante F; Sahara K; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Weiss MJ; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Ejaz A; Pawlik TM
    Eur J Surg Oncol; 2019 Jun; 45(6):1084-1091. PubMed ID: 30871884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma.
    Hu LS; Zhang XF; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
    Ann Surg Oncol; 2019 Aug; 26(8):2549-2557. PubMed ID: 31020501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes for Patients with Recurrent Intrahepatic Cholangiocarcinoma After Surgery.
    Park HM; Yun SP; Lee EC; Lee SD; Han SS; Kim SH; Park SJ
    Ann Surg Oncol; 2016 Dec; 23(13):4392-4400. PubMed ID: 27581609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrahepatic cholangiocarcinoma: Is there a role for liver transplantation?
    Kim P; Littau M; Baker TB; Abdelsattar Z; Tonelli C; Bunn C; Kulshrestha S; Luchette FA; Baker MS
    Surgery; 2022 Mar; 171(3):741-746. PubMed ID: 34895770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of major vascular resection on outcomes and survival in patients with intrahepatic cholangiocarcinoma: A multi-institutional analysis.
    Reames BN; Ejaz A; Koerkamp BG; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Martel G; Marsh JW; Pawlik TM
    J Surg Oncol; 2017 Aug; 116(2):133-139. PubMed ID: 28411373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival.
    Soares KC; Jolissaint JS; McIntyre SM; Seier KP; Gönen M; Sigel C; Nasar N; Cercek A; Harding JJ; Kemeny NE; Connell LC; Koerkamp BG; Balachandran VP; D'Angelica MI; Drebin JA; Kingham TP; Wei AC; Jarnagin WR
    Cancer Med; 2023 Jun; 12(11):12272-12284. PubMed ID: 37062071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity-matched National Cancer Database analysis.
    Kamarajah SK; Bednar F; Cho CS; Nathan H
    Cancer; 2021 Apr; 127(8):1266-1274. PubMed ID: 33320344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection.
    Lei Z; Xia Y; Si A; Wang K; Li J; Yan Z; Yang T; Wu D; Wan X; Zhou W; Liu J; Wang H; Cong W; Wu M; Pawlik TM; Lau WY; Shen F
    J Hepatol; 2018 Apr; 68(4):655-662. PubMed ID: 29155069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Geographic Disparities in Referral Rates and Oncologic Outcomes of Intrahepatic Cholangiocarcinoma: A Population-Based Study.
    Sutton TL; Walker BS; Nabavizadeh N; Grossberg A; Thomas CR; Lopez CD; Kardosh A; Chen EY; Sheppard BC; Mayo SC
    Ann Surg Oncol; 2021 Dec; 28(13):8152-8159. PubMed ID: 34448960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph Node Examination and Patterns of Nodal Metastasis Among Patients with Left- Versus Right-Sided Intrahepatic Cholangiocarcinoma After Major Curative-Intent Resection.
    Zhang XF; Xue F; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Cauchy F; Martel G; Koerkamp BG; Itaru E; Lv Y; Pawlik TM
    Ann Surg Oncol; 2023 Mar; 30(3):1424-1433. PubMed ID: 36400889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.
    Zhu J; Liu C; Li H; Ren H; Cai Y; Lan T; Wu H
    Cancer Med; 2023 Apr; 12(7):8184-8198. PubMed ID: 36645113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of major vascular resection in patients with intrahepatic cholangiocarcinoma.
    Ali SM; Clark CJ; Zaydfudim VM; Que FG; Nagorney DM
    Ann Surg Oncol; 2013 Jun; 20(6):2023-8. PubMed ID: 23263702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.